BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Stem cell
,
Biofuel
,
Bleomycin
,
rs7903146
,
FXYD4
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
h 89
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Fibroblasts serum starved treated with anisomycin for 3 or 6hr with or without H89 pre-treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involv…
Effect of quercetin, L-ergothioneine and H89 on sperm motility and kinematic pattern, plasma membran…
Intrahippocampal co-administration of nicotine and O-acetyl-L-carnitine prevents the H-89-induced sp…
Tadalafil Reversed H-89 - and Scopolamine - Induced Spatial Learning Impairments in Male Rats.
H89 Treatment Reduces Intestinal Inflammation and Candida albicans Overgrowth in Mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H.…
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or De…
Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults
Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)
The RBANS-H in Older Adults With Normal Hearing or Age-related Hearing Loss
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ